Gladstone-UCSF Institute of Genomic Immunology Seminar
Tuesday, October 15, 2024

Melody Smith, MD, MS

Assistant Professor, Division of Blood & Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University

Melody Smith, MD, MS, is a board-certified, fellowship-trained medical oncologist and hematologist. She received her BS at Vanderbilt University, and she received her MD with Distinction in Research from the University of Texas Southwestern Medical School in Dallas. She also completed an internship and residency in Internal Medicine at the University Texas Southwestern. She subsequently moved to Memorial Sloan Kettering Cancer Center (MSK) to complete her fellowship in Hematology & Medical Oncology. She joined the faculty at MSK in 2015 as an Instructor of Medicine on the Adult Bone Marrow Transplant Service, and she was promoted to Assistant Member Level 1 in 2017. During her time as junior faculty at MSK, she obtained a Master of Science from Weill Cornell Graduate School of Medical Sciences in Clinical & Translational Investigation. 

As of September 2021, she joined the faculty at Stanford University as an Assistant Professor on the BMT-CT Service in the Department of Medicine where she established her independent lab. Her research focuses on strategies to develop cellular immunotherapy from allogeneic as opposed to autologous sources (Ghosh A* and Smith M* et al. Nat Med 2017; * denotes co-first authorship). She also investigates the regulatory mechanisms for the impact of the intestinal microbiome on CAR-T cell outcomes (Smith M. et al. Nat Med 2022). Smith has received funding from several foundations, including the Damon Runyon Cancer Research Foundation, Be the Match Amy Strelzer Manasevit Research Program, and the V Foundation.

 

Details

Dates
October 15, 2024
Time
10:00-11:00am PDT
Location
Mahley Auditorium & Online
Audience
Gladstone and UCSF
Contact(s)







The Gladstone-UCSF Institute of Genomic Immunology Seminar Series showcases speakers at the intersection of genomic technology and immunology research with an aim to engineer the human immune system for therapeutic benefit. Speakers span technology development, synthetic biology, bioengineering, and the development and clinical application of immunotherapy. These talks are open to the Gladstone and UCSF communities.

Diversity, Equity, and Inclusion

At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.

We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.